this post was submitted on 16 Sep 2023
1170 points (96.1% liked)

Technology

60076 readers
4105 users here now

This is a most excellent place for technology news and articles.

Our Rules

  1. Follow the lemmy.world rules.
  2. Only tech related content.
  3. Be excellent to each another!
  4. Mod approved content bots can post up to 10 articles per day.
  5. Threads asking for personal tech support may be deleted.
  6. Politics threads may be removed.
  7. No memes allowed as posts, OK to post as comments.
  8. Only approved bots from the list below, to ask if your bot can be added please contact us.
  9. Check for duplicates before posting, duplicates may be removed

Approved Bots

founded 2 years ago
MODERATORS
L3s
[email protected]
[email protected]
L4s
enu
1170
New Vaccine Can Completely Reverse Autoimmune Diseases Like Multiple Sclerosis, Type 1 Diabetes, and Crohn’s Disease (scitechdaily.com)
submitted 1 year ago by [email protected] to c/technology
232 comments fedilink hide all child comments
 

Researchers from Pritzker Molecular Engineering, under the guidance of Prof. Jeffrey Hubbell, demonstrated that their compound can eliminate the autoimmune response linked to multiple sclerosis. Researchers at the University of Chicago's Pritzker School of Molecular Engineering (PME) have developed

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 10 points 1 year ago* (last edited 1 year ago)

The real reason it takes time is because we try not to harm people even in experimental drug testing. It would be much faster to simply toss shit at the wall and see what sticks, but that's not exactly humane. So we have to find analogues that hopefully mimick humans will enough, but they don't really work well. So it takes lots of time to build up enough evidence with those preliminary tests to convince the safety board to allow human trials. Then trials have to slowly scale up to limit the amount of people harmed by unforseen effects with a lot of time between as the safety board reviews the previous results before allowing the next test.

It's all good to do, but it does make development frustratingly slow sometimes. Especially when people are actively dying waiting for the new drugs.